Aspect Biosystems and JDRF to Develop 3D Bioprinted Treatment for Diabetes
Canadian 3D bioprinting firm Aspect Biosystems has unveiled a new partnership with the international diabetes research and advocacy organization JDRF.
LATEST NEWS
- 10 / 31 : A first in Vietnam as 3D printed chest wall surgery patient sees quick recovery
- 10 / 29 : Qwadra and Create it REAL Forge Partnership to Advance 3D Printing in Orthotics and Prosthetics
- 10 / 29 : LuxCreo’s New 3D Printed Sleep Apnea Devices Target $500 Billion MedTech Market
- 10 / 20 : Ricoh and Insight Surgery Deliver Custom 3D Printed Surgical Guides
- 10 / 18 : LUTYEN sells construction 3D printer to 3VIMA Construction 3D Printing
2024-11-05
